An apparent clinical pharmacokinetic drug–drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism
Crossref DOI link: https://doi.org/10.1007/s00280-017-3242-8
Published Online: 2017-03-17
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Ka
Stark, Franziska Schaedeli
Schlothauer, Tilman
Lahr, Angelika
Cosson, Valerie
Zhi, Jianguo
Habben, Kai
Tessier, Jean
Schick, Eginhard
Staack, Roland F.
Krieter, Oliver
License valid from 2017-03-17